Comfortable consultation room at Zabinski Urology in Melbourne, FL where men can discuss Peyronie's disease privately

Peyronie's Disease Care in Melbourne, FL

Discreet, expert evaluation and treatment for penile curvature, pain, and erectile changes

Affects:Roughly 1 in 10 adult men
Common Age:Men 40 to 70 years old
Phases:Acute (inflammatory), Chronic (fibrotic)
Treatments:Oral therapy, Xiaflex, surgery
Board-certified urologist meeting with a patient to discuss Peyronie's disease and treatment options

Understanding Peyronie's Disease

A common, treatable condition that deserves a calm, expert conversation

At Zabinski Urology in Melbourne, FL, we care for men with Peyronie's disease from across Brevard County and the Space Coast, including Palm Bay, Viera, Rockledge, Cocoa, Cocoa Beach, Merritt Island, Indialantic, Satellite Beach, and Suntree. Peyronie's disease is more common than most men realize, and the right evaluation can ease worry quickly. Our father and son urology team has spent decades helping men talk openly about sensitive concerns and find a treatment plan that fits their life.

Peyronie's disease is a connective tissue condition in which scar tissue, called a plaque, forms beneath the skin of the penis inside a layer known as the tunica albuginea. That plaque limits how the tissue stretches during an erection, which can lead to a noticeable bend or curvature, pain, indentation, shortening, or trouble achieving a firm erection. According to the American Urological Association, Peyronie's disease affects an estimated 6 to 10 percent of adult men, and many cases go unreported because men feel embarrassed to bring it up.

You do not have to live with the discomfort, the worry, or the impact on intimacy. Our board-certified urologists offer a thorough, patient-centered workup and a clear conversation about every option, from oral medication and testosterone replacement therapy for related concerns to Xiaflex injections and surgical correction when appropriate. Call (321) 372-1372 to schedule a private consultation.

Anatomical diagram showing how scar tissue forms inside the penis and creates curvature in Peyronie's disease

What Causes Peyronie's Disease?

Microtrauma, healing, and the formation of plaque

Although the exact trigger is not always known, most urologists believe Peyronie's disease begins with small injuries to the penis, often during intercourse, sports, or normal daily activity. In some men the tissue heals normally. In others, the body lays down extra collagen as it repairs the injury, and a firm plaque forms inside the tunica albuginea. That plaque does not stretch the way healthy tissue does, so the penis bends or shortens during erection.

Genetics also play a role. Men with a personal or family history of Dupuytren's contracture, a hand condition that thickens tissue in the palm, are more likely to develop Peyronie's disease. Connective tissue disorders, diabetes, high blood pressure, low testosterone, smoking, and pelvic or prostate surgery have also been linked to higher risk in research summarized by the National Institute of Diabetes and Digestive and Kidney Diseases. Age matters too: the condition is most often diagnosed in men between 40 and 70, though younger men can be affected.

The good news is that understanding the cause is not required to begin treatment. A careful exam, a few measurements, and a focused conversation about your symptoms give us everything we need to start.

Timeline graphic showing the acute inflammatory phase and chronic fibrotic phase of Peyronie's disease

The Acute and Chronic Phases of Peyronie's Disease

Why timing changes the treatment plan

Peyronie's disease typically moves through two distinct phases, and the right treatment depends on which phase you are in when you come to see us.

The acute, or inflammatory, phase usually lasts 6 to 18 months. During this stage the plaque is still forming, pain is more common (especially during erection), and the curvature can change from week to week. Because the tissue is still active, the goal of care in the acute phase is to control pain, slow plaque growth, and protect erectile function. Oral therapy, traction, and certain injectable treatments can be helpful, but most urologists do not recommend surgery while the disease is still changing.

The chronic, or fibrotic, phase begins once the plaque has stabilized, pain has eased, and the curvature has held steady for at least 3 months. At this point, the deformity is unlikely to improve on its own. This is the right moment to consider definitive treatment, including Xiaflex (collagenase clostridium histolyticum) injections or a surgical correction such as plication, plaque incision and grafting, or, in cases with severe erectile dysfunction, a penile implant. We will walk you through every choice, including realistic expectations for how straight, how long, and how firm the result will be.

Lifestyle and medical risk factors that contribute to Peyronie's disease

Common Risk Factors and Contributors

Why some men develop Peyronie's and others do not

01

Repeated Microtrauma

Small injuries during intercourse or sports that the body heals with scar tissue rather than normal collagen.

02

Family History

A father, brother, or close relative with Peyronie's disease or Dupuytren's contracture of the hand.

03

Connective Tissue Disorders

Conditions like Dupuytren's contracture, plantar fasciitis, and Ledderhose disease share related collagen biology.

04

Diabetes and Vascular Disease

High blood sugar and poor circulation impair healing and are linked to higher Peyronie's risk.

05

Low Testosterone

Reduced testosterone can affect penile tissue quality and is often present alongside Peyronie's disease.

06

Prior Pelvic or Prostate Surgery

Procedures such as radical prostatectomy can occasionally precede the development of curvature.

Board-certified urologists in Melbourne, FL

Why Choose Zabinski Urology for Peyronie's Disease Care in Melbourne, FL

Father and son urologists with 60+ combined years of experience

  • Board-Certified Urologists
  • Private, Discreet Setting
  • Full Range of Treatment Options
  • Local, Personal Care

How We Evaluate and Support Treatment of Peyronie's Disease

Clinic services that play a role in your workup and follow-up

Service Role in Peyronie's Care Visit Length Discomfort Follow-Up
Cystoscopy Used when urinary symptoms appear alongside curvature, to rule out other conditions 20 to 30 minutes Mild, with topical anesthetic As needed based on findings
Testosterone Replacement Therapy Supports tissue quality and erectile function when low T is confirmed by labs Brief visits, ongoing therapy Minimal Lab checks every 3 to 6 months
Emsella Pelvic Floor Therapy Strengthens pelvic floor muscles that support erection and sexual function 28 minutes per session None, fully clothed Series of 6 sessions then maintenance
Confident middle-aged man preparing to talk with his urologist about new penile symptoms

Signs You May Have Peyronie's Disease

When to schedule an evaluation

  • Noticeable Curvature
  • A Lump You Can Feel
  • Pain With Erection
  • Shortening or Indentation
  • Trouble Getting or Keeping an Erection
  • Difficulty With Intimacy

Frequently Asked Questions

About Peyronie's Disease

01 Will my Peyronie's disease go away on its own?

A small percentage of men, roughly 10 to 15 percent, see some natural improvement during the early acute phase. Most do not. Once the plaque stabilizes in the chronic phase, the curvature is unlikely to reverse without treatment. Coming in early lets us track changes and start care before the condition affects intimacy or self-confidence.

02 What is the exam like? Is it painful?

The appointment is straightforward and respectful. Your urologist will ask about your symptoms, examine the area while flaccid, and may gently palpate the shaft to feel for a plaque. We sometimes ask for photographs of the erection taken at home, or we may use a small injection to produce an erection in the office so we can measure curvature precisely. Discomfort is minimal, and we explain every step before we do it.

03 What is Xiaflex and how does it work?

Xiaflex is the brand name for collagenase clostridium histolyticum, an FDA-approved injectable that dissolves the collagen in the plaque. It is given as a series of injections, usually 4 cycles over several months, paired with gentle modeling exercises. Studies show it can reduce curvature by an average of 17 to 34 percent in appropriate candidates, and it works best for men with stable curvature between 30 and 90 degrees and no calcified plaque.

04 When is surgery the right choice?

Surgery is generally reserved for men in the chronic phase with stable, significant curvature that interferes with intercourse, particularly if injectable therapy has not delivered enough improvement. Common options include plication, where sutures shorten the longer side, and plaque incision with grafting, where the plaque is opened and a graft is placed. Men with severe erectile dysfunction plus curvature may benefit from a penile implant that corrects both at once.

05 Will treatment restore me to exactly how I was before?

Honest answer: most men see meaningful improvement, but no treatment guarantees a return to pre-disease anatomy. Realistic goals are straighter, more comfortable, and functional erections that allow satisfying intimacy. We talk through expected outcomes in detail before any decision so you know what is likely, what is possible, and what is unlikely.

06 Does Peyronie's disease cause cancer?

No. Peyronie's disease is a benign condition. The plaque is scar tissue, not a tumor. That said, any new lump warrants an exam so we can confirm what it is and rule out other concerns.

07 How soon can I be seen at Zabinski Urology?

We prioritize new evaluations for Peyronie's disease because waiting often increases anxiety. Most men can be seen within 1 to 2 weeks. Call (321) 372-1372 and our team will find a private appointment time that works for you.

Location129 W Hibiscus Blvd, Suite D
Melbourne , FL, 32901

Schedule Your Consultation

Scientific References

  1. PubMed (PMID: 26343845) - Nehra A, et al. Peyronie's Disease: AUA Guideline. The Journal of Urology, 2015. Establishes diagnostic and treatment recommendations including timing of intervention by phase.
  2. PubMed (PMID: 24119722) - Gelbard M, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum (CCH, Xiaflex) for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo-controlled phase 3 studies (IMPRESS I and II). Demonstrated mean curvature reduction of 34% versus placebo.
  3. PubMed (PMID: 22216761) - Hellstrom WJG, et al. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
  4. PubMed (PMID: 27036605) - Stuntz M, et al. The prevalence of Peyronie's disease in the United States: a population-based study. Estimated prevalence of 0.5 to 13% with most studies clustering between 3 and 9%.
  5. PubMed (PMID: 23859320) - Levine LA, Larsen SM. Surgery for Peyronie's disease. Review of plication, plaque incision/excision with grafting, and penile prosthesis outcomes.
  6. American Urological Association, Urology Care Foundation - Peyronie's Disease Patient Resource. Plain-language patient guide endorsed by the AUA.